Literature DB >> 19878382

Adiponectin is a link among inflammation, insulin resistance, and high-density lipoprotein cholesterol but is not associated with paraoxonase activity in premenopausal women.

Pinar Cetinalp-Demircan1, Selda Bekpinar, Figen Gurdol, Yusuf Orhan.   

Abstract

The aim of this study was to evaluate whether insulin sensitivity, inflammatory response, and plasma lipid profile are associated with circulating adiponectin levels in nondiabetic healthy women. The authors also assessed whether adiponectin has any effect on high-density lipoprotein cholesterol-linked paraoxonase 1 (PON-1) activity and on the susceptibility of low-density lipoproteins to oxidation. Plasma adiponectin was measured in 91 nondiabetic premenopausal women, and the patients were then divided into quartiles. Circulating adiponectin was found to be associated with body mass index (r=.55, P<.001). After adjustment for body mass index, adiponectin showed an inverse correlation with the homeostasis model assessment of insulin resistance (HOMA-IR) (r=-.41, P<.001) and a positive correlation with high-density lipoprotein cholesterol (r=.43, P<.001). In linear regression analysis, HOMA-IR, tumor necrosis factor alpha, and high-density lipoprotein cholesterol levels were found to be independently associated with adiponectin. However, high-density lipoprotein cholesterol-linked PON-1 activity and the susceptibility of low-density lipoproteins to in vitro oxidation did not seem to be related to plasma adiponectin concentrations. 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878382      PMCID: PMC8673336          DOI: 10.1111/j.1559-4572.2008.00048.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  23 in total

1.  Study of factors influencing the decreased HDL associated PON1 activity with aging.

Authors:  Ildiko Seres; Gyorgy Paragh; Elaine Deschene; Tamas Fulop; Abdelouahed Khalil
Journal:  Exp Gerontol       Date:  2004-01       Impact factor: 4.032

Review 2.  Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences.

Authors:  Michael Aviram; Mira Rosenblat
Journal:  Curr Opin Lipidol       Date:  2005-08       Impact factor: 4.776

3.  The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts.

Authors:  H W Eckerson; J Romson; C Wyte; B N La Du
Journal:  Am J Hum Genet       Date:  1983-03       Impact factor: 11.025

4.  Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes.

Authors:  Kolapo M Ajuwon; Michael E Spurlock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-12-16       Impact factor: 3.619

5.  Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans.

Authors:  Jens M Bruun; Aina S Lihn; Camilla Verdich; Steen B Pedersen; Soren Toubro; Arne Astrup; Bjorn Richelsen
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-05-07       Impact factor: 4.310

6.  Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population.

Authors:  Yukihiro Yamamoto; Hiroshi Hirose; Ikuo Saito; Motowo Tomita; Matsuo Taniyama; Koichi Matsubara; Yasunori Okazaki; Tatsuya Ishii; Kanako Nishikai; Takao Saruta
Journal:  Clin Sci (Lond)       Date:  2002-08       Impact factor: 6.124

7.  Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study.

Authors:  Bharti Mackness; Paul Durrington; Patrick McElduff; John Yarnell; Naheed Azam; Michael Watt; Michael Mackness
Journal:  Circulation       Date:  2003-05-19       Impact factor: 29.690

8.  Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression.

Authors:  Philip A Kern; Gina B Di Gregorio; Tong Lu; Negah Rassouli; Gouri Ranganathan
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

9.  Relationship of adiponectin to serum paraoxonase 1.

Authors:  Laszlo Bajnok; Eva Csongradi; Ildiko Seres; Zsuzsa Varga; Sara Jeges; Attila Peti; Zsolt Karanyi; Attila Juhasz; Emese Mezosi; Endre V Nagy; Gyorgy Paragh
Journal:  Atherosclerosis       Date:  2007-07-12       Impact factor: 5.162

10.  Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver.

Authors:  Hiroyuki Oku; Fumihiko Matsuura; Masahiro Koseki; Jose C Sandoval; Miyako Yuasa-Kawase; Kazumi Tsubakio-Yamamoto; Daisaku Masuda; Norikazu Maeda; Tohru Ohama; Masato Ishigami; Makoto Nishida; Ken-ichi Hirano; Shinji Kihara; Masatsugu Hori; Iichiro Shimomura; Shizuya Yamashita
Journal:  FEBS Lett       Date:  2007-09-29       Impact factor: 4.124

View more
  1 in total

1.  Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study.

Authors:  Christa Meisinger; Dennis Freuer; Achim Bub; Jakob Linseisen
Journal:  Lipids Health Dis       Date:  2021-07-31       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.